G protein-coupled receptor up-regulated in prostate cancer...

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S252300, C435S320100, C435S326000, C536S023100, C536S024300, C530S350000

Reexamination Certificate

active

06838258

ABSTRACT:
A novel gene (designated PHOR-1) that is highly overdressed in prostate and other cancers and its encoded protein are described. PHOR-1 is a G protein-coupled receptor with homology to receptors involved in olfaction. PHOR-1 in normal human tissues is restricted to prostate, and this gene is highly over-expressed in prostate cancer as well as in cancers of the kidney, uterus, cervix, stomach and rectum. Consequently, PHOR-1 provides a diagnostic and/or therapeutic target for prostate cancer.

REFERENCES:
patent: 20020192763 (2002-12-01), Xu et al.
patent: 20030022237 (2003-01-01), Feder et al.
patent: 1270724 (2003-01-01), None
patent: WO 9639435 (1996-12-01), None
patent: WO 9906550 (1999-02-01), None
patent: WO 0004149 (2000-01-01), None
patent: WO2002016548 (2000-02-01), None
patent: WO 0020590 (2000-04-01), None
patent: WO200261087 (2002-08-01), None
patent: WO200289747 (2002-11-01), None
patent: WO200292842 (2002-11-01), None
patent: WO2003009814 (2003-02-01), None
Bowie et al (Science, 1990, 257 : 1306-1310).*
Burgess et al, (Journal of Cell Biology, 1990, 11: 2129-2138).*
Lazar et al. Molecular and Cell Biology, 1988, 8: 1247-1252.*
Miller (1995, FASEB J., vol. 9, pp. 190-199).*
Deonarain (1998, Expert Opin. Ther. Pat., vol. 8, pp. 53-69).*
Verma (Sept. 1997, Nature, vol. 389, pp. 239-242).*
Crystal (1995, Science, vol. 270, p. 404-410).*
Alberts et al., Molecular Biology of the Cell, 3rd Edition (1994) p. 465.
Burgess et al., Journal of Cell Biology (1990) 11:2129-2138.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Gillies et al., Human Antibodies and Hybridomas (1990) 1(1):47-54.
Harrison, Immunol Series 49:411-464.
Jansen, Pediatric Res. (1995) 37(6):681-686.
Lazar et al., Molecular and Cell Biology (1988) 8:1247-1252.
Maniatis et al. (Eds.), Mol. Cloning (1989) Cold Spring Harbor Laboratory, Cold Spring Harbor, p. 17.31.
McLean and Hill, Eur. J. of Cancer (1993) 29A:2243-2248.
Shantz and Pegg, Int. J. of Biochem. and Cell Biol. (1999) 31:107-122.
Tao et al., The Journal of Immunology (1989) 143(8):2595-2601.
Bepler et al., Genomics (1999) 55(2):164-175.
EMBL Sequence Accession No. A06681.Gcg_Geneseq_D, Jun. 13, 2000 (first entry).
EMBL Sequence Accession No. AF101565, Jan. 29, 1999, Nov. 8, 2000.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Klein et al., Nat. Med. (1997) 3:402.
NAGENESEQ, EMBL Sequence Accesion No., X40518, Jun. 18, 1999 (first entry).
Pinto et al., Clin. Cancer Res. (1996) 2(9):1445-1451.
Reiter et al., Proc. Natl. Acad. Sci. USA (1998) 95:1735.
Sjogren, Immunotechnology (1997) 3(3):161-172.
Su et al., Proc. Natl. Acad. Sci. USA (1996) 93:7252.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

G protein-coupled receptor up-regulated in prostate cancer... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with G protein-coupled receptor up-regulated in prostate cancer..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and G protein-coupled receptor up-regulated in prostate cancer... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3371295

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.